3.31 USD
▲+0.18+4.09%
盘后 3.19 +0.31%
2026-08-03
市值
$1.76B
市盈率
—
EPS
-1.17
股息率
—
52 周区间
2.77 – 7.18
成交量
21.58M
Beta
0.99
目标价
7.25
52W 低 2.7752W 高 7.18
价格走势
公司简介
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat ...